Press release
Asia-Pacific Cancer Biomarkers Market–Estimated to reach USD 3.75 billion by 2021
Biomarkers are described as the biological molecules or genes assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery & development processes and assessment of disease conditions.
Cancer biomarkers are substances that are an indicative of the presence of cancer in the body. With the emerging importance to quantify and validate various disease conditions, many organizations, companies, and universities have stepped forward to contribute to the field of biomarkers discovery and quantification for better prognosis of disease conditions.
Get a comprehensive overview of the Asia-Pacific Cancer Biomarkers Market: http://www.marketdataforecast.com/market-reports/asia-pacific-cancer-biomarkers-market-2242/
Asia-Pacific Cancer Biomarkers Market: Drivers & Restraints
The Biomarkers in pharmaceutical industry, biomarkers in oncology & other diseases has attained utmost recognition due to global spread of cancer and other diseases. Factors such as technological Developments in omics technologies, augmented demand for personalized medicines in cancer therapies and increased use of biomarkers in drug discovery development and clinical trials are anticipated to boost the growth of the cancer biomarkers market during the forecast period. Lack of awareness about the procedure among people is restraining the market growth.
Get accurate market forecast and analysis on the Asia-Pacific Cancer Biomarkers Market. Request a sample to stay up-to-date on the main trends affecting this markethttp://www.marketdataforecast.com/market-reports/asia-pacific-cancer-biomarkers-market-2242/request-sample
Asia-Pacific Cancer Biomarkers Market: Segmentation
By DiseaseType
• Introduction
• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Cervical Cancer
• Other Cancers
• Y-o-Y Growth Analysis, By Disease
• Market Attractiveness Analysis, By Disease
• Market Share Analysis, By Disease
By Services
• Introduction
• Sample Preparation
• Assay development
• Biomarkers validation and testing
• Y-o-Y Growth Analysis, By Services
• Market Attractiveness Analysis, By Services
• Market Share Analysis, By Services
By Application
• Introduction
• Risk Assessment
• Development of molecular diagnostics
• Disease diagnosis
• Drug discovery
• Development and Drug formulation
• Y-o-Y Growth Analysis, By Application
• Market Attractiveness Analysis, By Application
• Market Share Analysis, By Application
By Type
• Introduction
• Protein Biomarkers
• Genetic biomarkers
• Y-o-Y Growth Analysis, By Type
• Market Attractiveness Analysis, By Type
• Market Share Analysis, By Type
By Profiling Technologies
• Omics technologies
o Genomics
o Proteomics
o Metabolomics
o Transcriptomics
o Pharmacogenomics
• Imaging technologies
• Immunoassays
• Cytogenetics
• Bioinformatics
• IVD multivariate index assays
• Y-o-Y Growth Analysis, By Profiling Technologies
• Market Attractiveness Analysis, By Profiling Technologies
• Market Share Analysis, By Profiling Technologies
Fromsimple data collation through secondary and primary research toad-hoc research requests relating to specific information, we provide our services via customization. Get customization athttp://www.marketdataforecast.com/market-reports/asia-pacific-cancer-biomarkers-market-2242/customize-report
Asia-Pacific Cancer Biomarkers Market: Overview
The CTC tests segment by test type accounted the largest share of the global cancer biomarkers market in 2016, and is expected to dominate the market during the forecast period from 2017 to 2025. Factors such as increase in prevalence of the various types of tumor and increasing incidences of cancer related to the vital organs drives the CTC tests segment. Although associated with non-drivers of selection, such as quick and easy order processing and availability from a contracted manufacturer, the cancer biomarkers market presents immense competition for new market players.
The lung cancer segment in terms of disease indication has the largest market share of the global cancer biomarkers market in 2016, and is expected to grow during the forecast period due to increasing prevalence of lung cancer in developing countries, growing cigarette smoking among the population, rising geriatric population, and technological advancements with regard to lesser side effects associated with biomarkers test and early detection of the illness drive demand for lung cancer diagnosis globally.According to WHO, 8.2 million people die each year from Cancer, which is estimated to be 13% of all deaths globally. There is growing incidence of cancer in Asia-Pacific region. According to WHO, in India, in 2012, around 537000 women and 477000 men were diagnosed with cancer.
Asia-Pacific Cancer Biomarkers Market: Region-wise Outlook
Based on geography, the market is analysed under various countries namely, China, India, Japan, South Korea and Australia. Asia-Pacific is estimated to grow at the highest CAGR of 16.20% during the forecast period 2015-2020 in which China is dominating the cancer biomarkers market and estimated to grow at highest CAGR in the forecast period.
Key Questions Answered
• What will be the market growth till 2021 and what will be the resultant market forecast in the year?
• What was the market size from 2016 to 2021 ?
• What is the current and future Cancer Biomarkers Market outlook worldwide? What trends are affecting the Asia-Pacific market?
• What is the competitive landscape and market share of major players in the Cancer Biomarkersspacein Asia-Pacific?
• What are the key, high growth markets that Cancer Biomarkersmanufacturers should expand into? Which market segments are growing the fastest?
• What are the unmet needs with theCancerBiomarkerscurrently on the market? How will emerging technologies fulfil these unmet needs?
• What is physician perception and market outlook of Cancer Biomarkers?
• What are the challenges and barriers that have hindered widespread adoption of Cancer Biomarkers?
• What are the key sustainability strategies adopted by market players ?
Asia-Pacific Cancer Biomarkers Market: Key Players
Some of the major players in this market are Abbott Laboratories, AgendiaBv, BiocurexInc, Biomerieux S.A., BiomodaInc, AstellasPharmaUsInc, Correlogic Systems Inc, Beckman Coulter Inc, Becton, Dickinson And Company, ClarientInc, DiadexusInc, AmbriliaBiopharma, AffymetrixInc and Aureon Laboratories Inc.
Reasons to buy Asia-Pacific Cancer Biomarkers MarketReport:
•Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
• Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
•Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
•Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
•A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
•Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
•Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Contact:
AbhishekShukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia-Pacific Cancer Biomarkers Market–Estimated to reach USD 3.75 billion by 2021 here
News-ID: 611791 • Views: …
More Releases from Market Data Forecast
Business Management Consulting Service Market is expected to witness a significa …
According to the latest research report published by Market Data Forecast, the global business management consulting services market is estimated to grow at a CAGR of 4.3% from 2024 to 2029 and be worth USD 1148 bn by 2029 from USD 930.15 bn in 2024.
The demand for consulting services is fuelled by the need for outside help from several enterprises, charitable organizations, and government agencies. Business management consulting advises organizations…
Antimicrobial Coatings Market expected to witness a significant growth rate of 1 …
According to the latest research report published by Market Data Forecast, the global antimicrobial coatings market is expected to grow at a CAGR of 11% during the forecast period 2024-2029. The market value was at USD 5 billion in 2023 and the value is expected to reach USD 9 billion by the end of 2029.
It is applied to stop microorganisms and other bacteria from growing and expanding. These are extensively…
End-User Computing Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the global end-user computing market is predicted to reach USD 15.33 billion in 2024 and USD 27.99 billion in 2029, growing at a CAGR of 12.8% during the forecast period.
Today's workforce is moving, with employees looking to access corporate data, apps, and online resources across more devices and locations. While supporting workplace mobility, minimizing risk, and maintaining compliance, end-user…
Smart Homes Market Size, Share, Growth Report 2024-2029
According to the latest research report published by Market Data Forecast, the global smart home market is predicted to reach USD 114.92 billion in 2024 and USD 221.46 billion by 2029, growing at a CAGR of 14.02% during the forecast period.
Advancements in IoT technology, as well as rising consumer demand for convenience and energy efficiency, are driving significant growth in the smart home industry. Smart thermostats, lighting, security systems, and…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
